VIA
Vident Investment Advisory Portfolio holdings
AUM
$2.9B
1-Year Return
24.65%
This Quarter Return
+8.58%
1 Year Return
+24.65%
3 Year Return
+82.72%
5 Year Return
+113.39%
10 Year Return
–
AUM
$3.29B
AUM Growth
+$322M
(+11%)
Cap. Flow
+$102M
Cap. Flow
% of AUM
3.1%
Top 10 Holdings %
Top 10 Hldgs %
10.67%
Holding
1,133
New
146
Increased
560
Reduced
374
Closed
47
Top Buys
| 1 |
iRhythm Technologies
IRTC
|
$15.2M |
| 2 |
Apple
AAPL
|
$9.64M |
| 3 |
AbbVie
ABBV
|
$8.74M |
| 4 |
Meta Platforms (Facebook)
META
|
$7.89M |
| 5 |
Comcast
CMCSA
|
$7.3M |
Top Sells
| 1 |
NUAN
Nuance Communications, Inc.
NUAN
|
$30.6M |
| 2 |
NVIDIA
NVDA
|
$10.3M |
| 3 |
Azenta
AZTA
|
$7.53M |
| 4 |
Rockwell Automation
ROK
|
$6.2M |
| 5 |
Intuitive Surgical
ISRG
|
$6.06M |
Sector Composition
| 1 | Technology | 29.71% |
| 2 | Healthcare | 14.09% |
| 3 | Energy | 12.28% |
| 4 | Industrials | 10.39% |
| 5 | Consumer Discretionary | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Qiagen
QGEN
$10.2B
| $216K | 0.01% |
4,208
-29,431
| -87% | -$1.51M |
|
1027
Veracyte
VCYT
$2.45B
| $216K | 0.01% |
+5,400
| New | +$216K |
|
1028
Alkermes
ALKS
$4.78B
| $214K | 0.01% |
+8,737
| New | +$214K |
|
1029
CarMax
KMX
$9.05B
| $214K | 0.01% |
1,657
+22
| +1% | +$2.84K |
|
1030
Regenxbio
RGNX
$468M
| $213K | 0.01% |
+5,482
| New | +$213K |
|
|
SAGE
1031
DELISTED
Sage Therapeutics
SAGE
| $213K | 0.01% |
+3,745
| New | +$213K |
|
1032
EnerSys
ENS
$3.83B
| $212K | 0.01% |
+2,173
| New | +$212K |
|
1033
NeoGenomics
NEO
$1.03B
| $212K | 0.01% |
+4,704
| New | +$212K |
|
|
NXGN
1034
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $212K | 0.01% |
+12,786
| New | +$212K |
|
1035
Adaptive Biotechnologies
ADPT
$1.95B
| $211K | 0.01% |
+5,155
| New | +$211K |
|
1036
Alector
ALEC
$288M
| $211K | 0.01% |
+10,124
| New | +$211K |
|
1037
Fiverr
FVRR
$866M
| $211K | 0.01% |
+870
| New | +$211K |
|
|
NVTA
1038
DELISTED
Invitae Corporation
NVTA
| $211K | 0.01% |
+6,245
| New | +$211K |
|
1039
Acadia Pharmaceuticals
ACAD
$4.33B
| $210K | 0.01% |
+8,608
| New | +$210K |
|
1040
Arcturus Therapeutics
ARCT
$445M
| $210K | 0.01% |
+6,205
| New | +$210K |
|
1041
MeiraGTx Holdings
MGTX
$613M
| $210K | 0.01% |
+13,546
| New | +$210K |
|
1042
Sarepta Therapeutics
SRPT
$1.93B
| $209K | 0.01% |
2,694
-3,483
| -56% | -$270K |
|
|
SDC
1043
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $209K | 0.01% |
+24,037
| New | +$209K |
|
1044
Natera
NTRA
$23.1B
| $208K | 0.01% |
+1,836
| New | +$208K |
|
1045
Schrodinger
SDGR
$1.38B
| $208K | 0.01% |
+2,748
| New | +$208K |
|
1046
Veeco
VECO
$1.44B
| $207K | 0.01% |
8,628
-39,608
| -82% | -$950K |
|
1047
Health Catalyst
HCAT
$231M
| $206K | 0.01% |
+3,708
| New | +$206K |
|
1048
PTC Therapeutics
PTCT
$4.52B
| $206K | 0.01% |
+4,863
| New | +$206K |
|
1049
AC Immune
ACIU
$216M
| $206K | 0.01% |
+25,974
| New | +$206K |
|
1050
4D Molecular Therapeutics
FDMT
$289M
| $205K | 0.01% |
+8,521
| New | +$205K |
|